Diheparin sodium is a low molecular weight heparin sodium, mainly used to treat unstable angina pectoris and non-ST segment elevation myocardial infarction; Prevention of deep vein thrombosis after operation; Prevention of clotting during hemodialysis and blood filtration; Treatment of acute deep vein thrombosis.

　　Adverse effects of sodium dalheparin: may cause bleeding, especially in large doses. Subcutaneous hematoma is common. Thrombocytopenia, skin necrosis, anaphylaxis, and bleeding are rare. Transient mild to moderate elevation of liver transaminase has been observed. Anaphylaxis is rare.

　　Qingdao Jiulong Pharmaceutical is Dalteparin API Company. In this small edition, we remind you to follow the doctor's advice when using dalteparin sodium to avoid unnecessary risks.